Amendment to Regulation (EU) 2018/782
2025/2573(RPS)
European solidarity: key to securing medicine access in a shifting geopolitical era
2026/2727(RSP)
Critical Medicines Act (CMA)
2025/2568(RSP)
Malaria Combat
2005/2531(RSP)
Multiple Sclerosis
2007/2570(RSP)
Medicinal products subject to medical prescription (amendment of Directive 2001/83/EC)
2008/0256(COD)
Developing Countries: Vaccine Access
2009/2720(RSP)
Flu Epidemic
2009/2602(RSP)
Pharma Package & Health
2009/2506(RSP)
Access to Life-Saving Medicines
2014/2831(RSP)
Medicine Shortages
2020/2581(RSP)
Comirnaty Vaccine Authorisation
2022/2941(RSP)
Granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for
2022/2928(RSP)
The annual renewal of the conditional marketing authorisation for the medicinal product for human use "Veklury -
2022/2661(RSP)
Gardasil 9: Marketing Objection
2023/2623(RSP)
2022 Discharge: EMA
2023/2156(DEC)
The market of Northern Ireland
2023/0064(COD)
EU Global Health Strategy
2023/2642(RSP)
Respiratory Infections & Drug Shortages
2023/2510(RSP)
Pharmaceuticals in Environment
2019/2816(RSP)
EMA Seat Location
2017/0328(COD)
2016 Discharge: EMA
2017/2154(DEC)
2016 Discharge: IMI 2
2017/2184(DEC)
GMP: Human Medicinal Products
2017/2684(RPS)
Falsified Medicines
2008/0261(COD)
Pharmacovigilance (Amendment)
2008/0257(COD)